Obermatt
See Similar Stocks →

Flags

Financial distress

Tempus AI

NSQ:TEM · US88023B1035
Life Sciences Tools & ServicesMedium

360

28
Profit price88
Owner Earnings Yield1
Dividend Yield1
Price/Sales58
EV / Gross Profit33
Price/Book3
Return on Capital7
Cash Return on Capital11
Return on Equity1
EBIT Margin11
Gross Profitability87
Accruals71
Owner Earnings Margin21
Sales growth88
Profit growth56
Reinvestment69
Price momentum17
Debt load13
Refinancing64
Debt Payback1
Liquidity53
Analyst ratings23
Opinion Changes50
Price Target Upside81
Market mood81
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Tempus AI doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
TypePublic Company
ExchangeNASDAQGS
Founded2015
Employees2,619
Websiteinvestors.tempus.com
ISINUS88023B1035
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Artificial IntelligenceGeneticsHealth DiagnosticsHematologyMachine LearningData IntegrationPredictive AnalyticsOncologyAnalyticsBiotechnologyClinical TrialsHealth CareMedicalSoftware

Description

Tempus AI, Inc. (Tempus) operates as a healthcare technology company. The company focuses on bringing artificial intelligence and machine learning to healthcare in order to improve the care of patients across multiple diseases. The company combines…

Analysis

Middle-of-the-road

Tempus AI, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is stretched. The company scores 4/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
20
2026

All-time high

20

Jun 2026

All-time low

16

Mar 2026

Average rank

18

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
58
—
—
—
Price/Earnings
100
—
—
—
Price/Book
3
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
38
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Tempus AI with its peers
Fulgent Genetics
NMQ:FLGT
4
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Champions Oncology
NAQ:CSBR
32
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Quest Diagnostics
NYQ:DGX
35
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Castle Biosciences
NMQ:CSTL
10
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
OmniAb
NMQ:OABI
61
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Alpha Teknova
NMQ:TKNO
32
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →